Overview

Bioavailability of Doravirine (MK-1439) Experimental Nano Formulations in Healthy Adults (MK-1439-046)

Status:
Completed
Trial end date:
2015-12-24
Target enrollment:
Participant gender:
Summary
This study aims to evaluate and compare the relative bioavailability of different doravirine (MK-1439) experimental nano formulations (NFs) with that of a doravirine film coated tablet.
Phase:
Phase 1
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.